<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="610">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04373486</url>
  </required_header>
  <id_info>
    <org_study_id>7840</org_study_id>
    <nct_id>NCT04373486</nct_id>
  </id_info>
  <brief_title>Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels</brief_title>
  <acronym>COVID-APE</acronym>
  <official_title>Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Reports of acute pulmonary embolism (APE) associated with COVID-19 have emerged in the
      literature. For example, Chen et al. described 25 pulmonary CT angiograms examinations from
      1008 COVID-19 patients; 10 were positive for pulmonary embolism mostly as segmental or
      sub-segmental APE. Case reports of APE in Covid-19 patients have been published. Cui et al.
      found an incidence of deep venous thrombosis in intensive care unit (ICU) patients with
      severe Covid-19 pneumonia near to 25% (20/81), however without any correlation with potential
      APE.

      Despite these initial reports, it is not clear whether APE is more frequent in Covid-19
      patients or if the association is just random. In favor of the former, D-dimer levels have
      been reported as elevated in patients with Covid-19 by two studies, and it has been suggested
      an independent association between the severity of the disease and the level of D-dimer.
      Finally, Tang et al. showed that anticoagulant therapy is associated with a decreased
      mortality at Day-28 in severe Covid-19 patients, in favor of a possible associated
      coagulopathy. The purpose of this study is to describe the rate of pulmonary embolus in
      patients classified as COVID-19 infection and who underwent chest CT angiography.

      The purpose of this study is to describe the rate of pulmonary embolus in patients classified
      as COVID-19 infection and who underwent chest CT angiography.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 3, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2020</completion_date>
  <primary_completion_date type="Actual">April 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of positivity for Acute Pulmonary Embolism</measure>
    <time_frame>March 1, 2020 - March 31, 2020</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Covid-19 With Positive RT-PCR</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with positive SARS-Cov-2 RT-PCR
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Positive SARS-Cov-2 RT-PCR

          -  Chest CT angiography available

          -  Patient is aged 18yo or above

        Exclusion Criteria:

          -  Expressed opposition to participate

          -  Adults under guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Mickaël OHANA, MD, PhD</last_name>
    <phone>33 3 69 55 11 17</phone>
    <email>mickael.ohana@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saïd CHAYER, PhD, HDR</last_name>
    <phone>33 3 88 11 66 90</phone>
    <email>said.chayer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Radiologie B - NHC</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mickaël OHANA, MD, PhD</last_name>
      <phone>33 3 69 55 11 17</phone>
      <email>mickael.ohana@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Mickaël OHANA, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ian LEONARD-LORANT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xavier DELABRANCHE, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François SEVERAC, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie HELMS, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Coralie PAUZET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier COLLANGE, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Françis SCHNEIDER, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aissam LABANI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascal BILBAULT, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sébastien MOLIERE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre LEYENDECKER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine ROY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2020</study_first_posted>
  <last_update_submitted>April 30, 2020</last_update_submitted>
  <last_update_submitted_qc>April 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Covid-19</keyword>
  <keyword>Pulmonary Embolism</keyword>
  <keyword>CT angiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

